FDA granted Fast Track designation for IO-202, a first-in-class myeloid checkpoint inhibitor targeting leukocyte immunoglobulin-like receptor B4 (LILRB4, also known as ILT3) for the treatment of patients with relapsed or refractory acute myeloid leukemia.
Craig Thompson said he would step down from his roles as president and CEO of Memorial Sloan Kettering Cancer Center.
Bill Cance will step down from his role as chief medical and scientific officer of the American Cancer Society.
To better understand the demographics of catchment areas, and where overlaps and gaps in coverage may exist, the Association of American Cancer Institutes surveyed its members in late 2020.
Vince Jensen was named chief clinical operating officer of City of Hope. Jensen will lead clinical operations on City of Hope’s main campus in Los Angeles and throughout its network of more than 35 care locations in Southern California.
Kristin Ludwig was named vice president of global corporate communications at EQRx.
Following its proposal for a $633 million, 500,000-square-foot cancer center on Chicago’s South Side, the University of Chicago Medicine is beginning its community engagement effort with a virtual public meeting, set by the Illinois Health Facilities and Services Review Board for 10 a.m. Feb. 15 (The Cancer Letter, Feb. 4, 2022).
The Legorreta Cancer Center at Brown University announced the awardees of the 2022 Pilot grant competition.
Since COVID-19 made its way to the United States, we have seen a stream of worrying news of the pandemic’s impact on cancer care in the U.S., including 9.4 million missed screenings for just about all forms of cancer. While screening rates rebounded in the fall of 2020, there’s a growing concern from oncologists that screenings haven’t returned to pre-pandemic levels for everyone.
Breast cancer has surpassed lung cancer as the leading cause of cancer death among Black women as of 2019, according to a report from the American Cancer Society.
